Literature DB >> 2807535

Photolabeling of Glu-129 of the S-1 subunit of pertussis toxin with NAD.

J T Barbieri1, L M Mende-Mueller, R Rappuoli, R J Collier.   

Abstract

UV irradiation was shown to induce efficient transfer of radiolabel from nicotinamide-labeled NAD to a recombinant protein (C180 peptide) containing the catalytic region of the S-1 subunit of pertussis toxin. Incorporation of label from [3H-nicotinamide]NAD was efficient (0.5 to 0.6 mol/mol of protein) relative to incorporation from [32P-adenylate]NAD (0.2 mol/mol of protein). Label from [3H-nicotinamide]NAD was specifically associated with Glu-129. Replacement of Glu-129 with glycine or aspartic acid made the protein refractory to photolabeling with [3H-nicotinamide]NAD, whereas replacement of a nearby glutamic acid, Glu-139, with serine did not. Photolabeling of the C180 peptide with NAD is similar to that observed with diphtheria toxin and exotoxin A of Pseudomonas aeruginosa, in which the nicotinamide portion of NAD is transferred to Glu-148 and Glu-553, respectively, in the two toxins. These results implicate Glu-129 of the S-1 subunit as an active-site residue and a potentially important site for genetic modification of pertussis toxin for development of an acellular vaccine against Bordetella pertussis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2807535      PMCID: PMC259866          DOI: 10.1128/iai.57.11.3549-3554.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Expression and secretion of pertussis toxin subunit S1 in Bacillus subtilis.

Authors:  K Runeberg-Nyman; O Engström; S Löfdahl; S Ylöstalo; M Sarvas
Journal:  Microb Pathog       Date:  1987-12       Impact factor: 3.738

2.  Subunit S1 of pertussis toxin: mapping of the regions essential for ADP-ribosyltransferase activity.

Authors:  M Pizza; A Bartoloni; A Prugnola; S Silvestri; R Rappuoli
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

3.  Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope.

Authors:  W N Burnette; W Cieplak; V L Mar; K T Kaljot; H Sato; J M Keith
Journal:  Science       Date:  1988-10-07       Impact factor: 47.728

4.  Expression and immunological properties of the five subunits of pertussis toxin.

Authors:  A Nicosia; A Bartoloni; M Perugini; R Rappuoli
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

5.  ADP-ribosyltransferase mutations in the catalytic S-1 subunit of pertussis toxin.

Authors:  J T Barbieri; G Cortina
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

Review 6.  Virulence factors of Bordetella pertussis.

Authors:  A A Weiss; E L Hewlett
Journal:  Annu Rev Microbiol       Date:  1986       Impact factor: 15.500

7.  Activities of complete and truncated forms of pertussis toxin subunits S1 and S2 synthesized by Escherichia coli.

Authors:  C Locht; W Cieplak; K S Marchitto; H Sato; J M Keith
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

8.  Pseudomonas aeruginosa exotoxin A: effects of mutating tyrosine-470 and tyrosine-481 to phenylalanine.

Authors:  M Lukac; R J Collier
Journal:  Biochemistry       Date:  1988-10-04       Impact factor: 3.321

9.  Amino acid sequence homology between the enzymic domains of diphtheria toxin and Pseudomonas aeruginosa exotoxin A.

Authors:  S F Carroll; R J Collier
Journal:  Mol Microbiol       Date:  1988-03       Impact factor: 3.979

10.  Active site of Pseudomonas aeruginosa exotoxin A. Glutamic acid 553 is photolabeled by NAD and shows functional homology with glutamic acid 148 of diphtheria toxin.

Authors:  S F Carroll; R J Collier
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.486

View more
  10 in total

1.  Modification of a mammalian cell protein in the presence of [32P-adenylate]NAD: evidence for ADP ribosylation activity associated with Helicobacter pylori.

Authors:  Carlos W Nossa; Steven R Blanke
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.

Authors:  S M Loosmore; G R Zealey; H A Boux; S A Cockle; K Radika; R E Fahim; G J Zobrist; R K Yacoob; P C Chong; F L Yao
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

3.  Scabin, a Novel DNA-acting ADP-ribosyltransferase from Streptomyces scabies.

Authors:  Bronwyn Lyons; Ravikiran Ravulapalli; Jason Lanoue; Miguel R Lugo; Debajyoti Dutta; Stephanie Carlin; A Rod Merrill
Journal:  J Biol Chem       Date:  2016-03-21       Impact factor: 5.157

Review 4.  The family of bacterial ADP-ribosylating exotoxins.

Authors:  K M Krueger; J T Barbieri
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

5.  Common structure of the catalytic sites of mammalian and bacterial toxin ADP-ribosyltransferases.

Authors:  I J Okazaki; J Moss
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

6.  Photolabelling of mutant forms of the S1 subunit of pertussis toxin with NAD+.

Authors:  W Cieplak; C Locht; V L Mar; W N Burnette; J M Keith
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

Review 7.  Clostridial ADP-ribosylating toxins: effects on ATP and GTP-binding proteins.

Authors:  K Aktories
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

8.  Effect of site-directed mutagenic alterations on ADP-ribosyltransferase activity of the A subunit of Escherichia coli heat-labile enterotoxin.

Authors:  Y Lobet; C W Cluff; W Cieplak
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

9.  Effects of site-directed mutagenesis of Escherichia coli heat-labile enterotoxin on ADP-ribosyltransferase activity and interaction with ADP-ribosylation factors.

Authors:  L A Stevens; J Moss; M Vaughan; M Pizza; R Rappuoli
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 10.  The History of Pertussis Toxin.

Authors:  Camille Locht; Rudy Antoine
Journal:  Toxins (Basel)       Date:  2021-09-05       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.